PT357 – Dr. Hans Eriksson – Precision Psychiatry, Ketabon, and The Stress Response System

Psychedelics Today

In this episode, David interviews Dr. Hans Eriksson: clinical psychiatrist and Chief Medical Officer at HMNC Brain Health, which is currently in Phase 2 trials for Ketabon, a non-dissociative, prolonged-release oral capsule.

www.psychedelicstoday.com

More description

In this episode, David interviews Dr. Hans Eriksson: clinical psychiatrist and Chief Medical Officer at HMNC Brain Health, which is currently in Phase 2 trials for Ketabon, a non-dissociative, prolonged-release oral capsule.

www.psychedelicstoday.com

2022-09-20 58 min
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.